Reducing Time to Market for New Drugs

Science-driven and research focused, this world-renowned biopharmaceutical companies’ products are used to treat some of the most challenging healthcare problems, including cancer, cardiovascular, metabolic, respiratory, inflammatory and autoimmune diseases.

Challenge

Despite its financial and medical success, with 60,000 workers, 6,000 systems and decades of R&D work behind it, the company faces the same problem that besets all large pharmaceutical companies: a hundred million files containing critical information, are spread out across the world in thousands of repositories. Key issues include:

• Turning millions of pages of drug research created at every stage of development into useful insights
• Making information available in local market language and context
• Creating a single platform to access disparate systems fast and easy

Solution

Implement an enterprise-level platform to make the process for all knowledge workers more efficient and information more accessible.

Enable the search team to create applications that unlock the knowledge stored in hundreds of millions of documents.

The ability to track down fraudulent websites so they can be shut down.

Increase the efficiency of the drug development process, and shorten time-to-market.

Annualized Results

The Sinequa solution included identifying and quantifying the benefit of solving life science specific business issues. The following results include the corresponding annual benefit:

• Decreasing time required to bring drugs to marketIncrease revenue by speeding delivery of marketing materials to local markets
  • Increase potential for revenue by identifying research opportunities within old data
  • Increase revenue and reduce regulatory risk by identifying fraudulent company websites and shut them down
  • Decreasing regulatory and privacy compliance risk – potentially saving millions
• Increasing productivity of project teams
• Find experts for faster assembly of project teams